{
  "generatedAt": "2026-09-28T15:54:21.937Z",
  "note": "Evidence Desk screening log: every record the desk identified and what happened to it. Identifiers and reason codes only. CLAUDE.md §11.",
  "counts": {
    "excluded": 42,
    "published": 8,
    "queued": 5
  },
  "rows": [
    {
      "ids": [
        "nct:NCT06238726"
      ],
      "kind": "trial",
      "title": "Nudging Patients to Increase Shingles Vaccination",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT01915212"
      ],
      "kind": "trial",
      "title": "Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection",
      "disposition": "published",
      "reason": null,
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT05701800"
      ],
      "kind": "trial",
      "title": "A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1468 in Healthy Adults ≥50 Years of Age",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT07818356"
      ],
      "kind": "trial",
      "title": "Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT07753265"
      ],
      "kind": "trial",
      "title": "A Study on the Live-Attenuated Herpes Zoster Vaccine for Sequential Booster Immunization Following Recombinant Herpes Zoster Vaccine",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT05580458"
      ],
      "kind": "trial",
      "title": "Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT07712380"
      ],
      "kind": "trial",
      "title": "A Study Exploring the Effect of Adjuvanted RZV or RSVPreF3 Vaccines on Coronary Plaque Progression in Adults >=50 Years of Age at Risk for Cardiovascular Events",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT03911388"
      ],
      "kind": "trial",
      "title": "HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT06070961"
      ],
      "kind": "trial",
      "title": "Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT07817108"
      ],
      "kind": "trial",
      "title": "Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT02444936"
      ],
      "kind": "trial",
      "title": "ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ Tumors",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT05683457"
      ],
      "kind": "trial",
      "title": "A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "nct:NCT05604911"
      ],
      "kind": "trial",
      "title": "Herpes Virus Infections in Kidney Transplant Patients",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1080/21645515.2026.2735737",
        "pmid:42757534",
        "pmcid:PMC13596908",
        "epmc:MED:42757534"
      ],
      "kind": "paper",
      "title": "Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1371/journal.ppat.1014339",
        "pmid:42424315",
        "pmcid:PMC13349171",
        "epmc:MED:42424315"
      ],
      "kind": "paper",
      "title": "Glycoprotein G enables HSV-2 neuroinvasion and provides protection as a glycosylated vaccine antigen",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/research/glycoprotein-g-hsv-2-vaccine-antigen-mice-2026.md",
        "src/content/verification/glycoprotein-g-hsv-2-vaccine-antigen-mice-2026.json"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.64898/2026.09.14.751393",
        "epmc:PPR:PPR1324311"
      ],
      "kind": "preprint",
      "title": "Tissue-Resident and Effector-Memory Lymphocyte Recruitment to the Ocular Mucosa Requires CCL28/CCR10 Signaling During Recurrent HSV-1 Infection",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.virusres.2026.199785",
        "pmid:42586214",
        "pmcid:PMC13520091",
        "epmc:MED:42586214"
      ],
      "kind": "paper",
      "title": "Expression and immunogenicity of a rabies virus glycoprotein-HSV-2 ICP35 fusion antigen delivered by an mRNA-LNP formulation",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.antiviral.2026.106494",
        "pmid:42532196",
        "epmc:MED:42532196"
      ],
      "kind": "paper",
      "title": "A high-throughput screen to identify potential inhibitors of HSV-2",
      "disposition": "excluded",
      "reason": "out-of-scope-nonvaccine",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.21203/rs.3.rs-9890379/v1",
        "epmc:PPR:PPR1279970"
      ],
      "kind": "preprint",
      "title": "Stepwise Enhancement of HPV16 E6/E7 mRNA Vaccine Efficacy Using HSV-1 gD Epitope Incorporation and Immune-Modulating Agents",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.20944/preprints202608.0733.v1",
        "epmc:PPR:PPR1296700"
      ],
      "kind": "preprint",
      "title": "Live-Attenuated HSV-1 VC2 Vectoring Capsid-Displayed HPV-16 E7m Elicits Th1-Polarized CD8+ T Cell Responses and Protection Against Cervical Cancer Challenge",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.survophthal.2026.07.003",
        "pmid:42435942",
        "epmc:MED:42435942"
      ],
      "kind": "paper",
      "title": "Herpes simplex keratitis: An epidemiological and public health review",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1177/00368504261492492",
        "pmid:42775839",
        "epmc:MED:42775839"
      ],
      "kind": "paper",
      "title": "Sexually transmitted infection syndemic interactions: Biological amplification between HIV, HSV-2, syphilis, and HPV and implications for co-treatment strategies",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "pmcid:PMC13298932",
        "epmc:PMC:PMC13298932"
      ],
      "kind": "paper",
      "title": "HSV-2 gC2 mRNA immunization in mice protects by producing antibodies that bind immune evasion epitopes",
      "disposition": "excluded",
      "reason": "duplicate",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.carres.2026.110052",
        "pmid:42531700",
        "epmc:MED:42531700"
      ],
      "kind": "paper",
      "title": "A heparan sulfate-mimetic derivative of botryosphaeran with antiviral activity against herpes simplex virus",
      "disposition": "excluded",
      "reason": "out-of-scope-nonvaccine",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.20944/preprints202608.1846.v1",
        "epmc:PPR:PPR1306293"
      ],
      "kind": "preprint",
      "title": "Can Herpesvirus Infections Influence When and How We Age",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.jcjo.2026.08.028",
        "pmid:42727925",
        "epmc:MED:42727925"
      ],
      "kind": "paper",
      "title": "Recurrent herpes simplex virus keratitis associated with recombinant zoster vaccination",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1128/jvi.00653-26",
        "pmid:42377976",
        "pmcid:PMC13386910",
        "epmc:MED:42377976"
      ],
      "kind": "paper",
      "title": "Alpha-herpesvirus UL55 synergizes with ICP27 to suppress type I interferon production through conserved and host-adapted mechanisms",
      "disposition": "excluded",
      "reason": "non-human-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.3390/neurolint18070125",
        "pmid:42506046",
        "pmcid:PMC13415037",
        "epmc:MED:42506046"
      ],
      "kind": "paper",
      "title": "Recent Insights into the Role of Herpesviridae in Alzheimer's Disease: A Structured Narrative Review Based on a Systematic Literature Search",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1007/s00284-026-05018-6",
        "pmid:42340456",
        "epmc:MED:42340456"
      ],
      "kind": "paper",
      "title": "Viral Infections and Neurodegenerative Diseases: Reinterpreting the Crosstalk Through a Dual-Role Lens",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.omton.2026.201284",
        "pmid:42519393",
        "pmcid:PMC13382575",
        "epmc:MED:42519393"
      ],
      "kind": "paper",
      "title": "Oncolytic virus-mediated remodeling of tumor microenvironment enhances efficacy of an HPV16 E6/E7 mRNA vaccine in an HPV-positive tumor",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1208/s12248-026-01267-2",
        "pmid:42618860",
        "epmc:MED:42618860"
      ],
      "kind": "paper",
      "title": "Industry Perspective on Translational and Clinical Pharmacology Aspects of Viral-based Gene Therapies and Vaccines-Key Considerations and Learnings From Approved Products",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.3389/fimmu.2026.1751672",
        "pmid:42500662",
        "pmcid:PMC13395927",
        "epmc:MED:42500662"
      ],
      "kind": "paper",
      "title": "The cell-mediated adaptive immune response to herpes simplex virus type 1 encephalitis: mechanisms and clinical implications",
      "disposition": "excluded",
      "reason": "out-of-scope-nonvaccine",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.clim.2026.110747",
        "pmid:42425185",
        "epmc:MED:42425185"
      ],
      "kind": "paper",
      "title": "Immunopathogenesis of NMDA receptor encephalitis",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.3390/ijms27156682",
        "pmid:42589339",
        "pmcid:PMC13466419",
        "epmc:MED:42589339"
      ],
      "kind": "paper",
      "title": "Clinical Progress in Virotherapy: Application and Future Prospects in Head and Neck Cancer",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1007/s13205-026-05016-2",
        "pmid:42632941",
        "pmcid:PMC13498545",
        "epmc:MED:42632941"
      ],
      "kind": "paper",
      "title": "Advances in gene transfer technologies: comparing viral and non-viral vectors for therapeutic applications",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1007/s00280-026-04911-y",
        "pmid:42423743",
        "epmc:MED:42423743"
      ],
      "kind": "paper",
      "title": "Anti-PD-1 single-chain variable fragments in cancer immunotherapy: from molecular engineering to clinical translation",
      "disposition": "excluded",
      "reason": "hsv-as-vector",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.cmi.2026.09.011",
        "pmid:42731628",
        "epmc:MED:42731628"
      ],
      "kind": "paper",
      "title": "Beyond Koplik spots: aphthous-like ulcers as a novel enanthem in adolescent and adult measles",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.idcr.2026.e02656",
        "pmid:42405178",
        "pmcid:PMC13332449",
        "epmc:MED:42405178"
      ],
      "kind": "paper",
      "title": "A case of herpes zoster in immune-competent and well-nourished 10-year-old girl",
      "disposition": "excluded",
      "reason": "other-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1177/13524585261475100",
        "pmid:42590993",
        "epmc:MED:42590993"
      ],
      "kind": "paper",
      "title": "Gynecologic complications of disease-modifying therapy in women with multiple sclerosis",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.bbih.2026.101301",
        "pmid:42473682",
        "pmcid:PMC13380788",
        "epmc:MED:42473682"
      ],
      "kind": "paper",
      "title": "Associations of viral infections and antiviral vaccinations with anti-NMDAR and other forms of autoimmune encephalitis",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1002/btpr.88521",
        "pmid:42400311",
        "epmc:MED:42400311"
      ],
      "kind": "paper",
      "title": "Purification and concentration of model viruses using single-pass tangential flow filtration",
      "disposition": "excluded",
      "reason": "non-human-herpesvirus",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1016/j.cmi.2026.08.013",
        "pmid:42601017",
        "epmc:MED:42601017"
      ],
      "kind": "paper",
      "title": "Immunomodulating treatments for bacterial meningitis and viral encephalitis",
      "disposition": "excluded",
      "reason": "out-of-scope-nonvaccine",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1159/000553536",
        "pmid:42461883",
        "epmc:MED:42461883"
      ],
      "kind": "paper",
      "title": "Community-Acquired CNS Infections in Western Asia (2010-2025): A Systematic Review",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "doi:10.1186/s12929-026-01277-4",
        "pmid:42509561",
        "pmcid:PMC13404113",
        "epmc:MED:42509561"
      ],
      "kind": "paper",
      "title": "The current landscape of mRNA therapy and the strategies for mRNA purification and dsRNA removal",
      "disposition": "excluded",
      "reason": "no-hsv-vaccine-content",
      "paths": [],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:gsk4108771a"
      ],
      "kind": "program",
      "title": "GSK4108771A",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/gsk4108771a.md"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:herpv"
      ],
      "kind": "program",
      "title": "HerpV",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/herpv.md"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:vcl-hb01"
      ],
      "kind": "program",
      "title": "VCL-HB01",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/vcl-hb01.md"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:ppjv7630"
      ],
      "kind": "program",
      "title": "pPJV7630",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/ppjv7630.md"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:bcht-hsv-mrna-vaccine"
      ],
      "kind": "program",
      "title": "BCHT HSV mRNA vaccine",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/bcht-hsv-2-mrna.md"
      ],
      "date": "2026-09-28"
    },
    {
      "ids": [
        "program:g103"
      ],
      "kind": "program",
      "title": "G103",
      "disposition": "published",
      "reason": null,
      "paths": [
        "src/content/candidates/g103.md"
      ],
      "date": "2026-09-28"
    }
  ]
}